These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
150 related articles for article (PubMed ID: 22028266)
1. [Seroconversion and immune response after anti-HBV vaccination in patients on chronic hemodialysis: comparison of two vaccines]. Polito P; Di Lullo L; Iannacci GR; Cecilia A; Galderisi C; Gorini A G Ital Nefrol; 2011; 28(5):525-30. PubMed ID: 22028266 [TBL] [Abstract][Full Text] [Related]
2. The evaluation of immune responses that occur after HBV infection and HBV vaccination in hemodialysis patients. Kara IH; Yilmaz ME; Suner A; Kadiroglu AK; Isikoglu B Vaccine; 2004 Sep; 22(29-30):3963-7. PubMed ID: 15364445 [TBL] [Abstract][Full Text] [Related]
3. Antibody response to hepatitis B vaccine in end-stage renal disease patients. Chow KM; Law MC; Leung CB; Szeto CC; Li PK Nephron Clin Pract; 2006; 103(3):c89-93. PubMed ID: 16534237 [TBL] [Abstract][Full Text] [Related]
4. Hepatitis B surface antigenemia following recombinant Engerix B hepatitis B vaccine in an 81-year-old ESRD patient on hemodialysis. Onuigbo MA; Nesbit A; Weisenbeck J; Hurlburt J Ren Fail; 2010 May; 32(4):531-2. PubMed ID: 20446799 [TBL] [Abstract][Full Text] [Related]
5. Polymethylmethacrylate strengthens antibody response in hemodialysis patients not responding to hepatitis B vaccine: preliminary data. Duranti E; Duranti D Minerva Med; 2011 Dec; 102(6):469-74. PubMed ID: 22193378 [TBL] [Abstract][Full Text] [Related]
6. Comparative immunogenicity of 2 recombinant hepatitis B vaccines (GeneVac-B and Engerix-B) in adult patients with chronic renal failure. Rajapurkar MM; Gang S; Dabhi M; Kulkarni PS J Nephrol; 2007; 20(5):596-601. PubMed ID: 17918146 [TBL] [Abstract][Full Text] [Related]
7. A randomized clinical trial of immunization with combined hepatitis A and B versus hepatitis B alone for hepatitis B seroprotection in hemodialysis patients. Tung J; Carlisle E; Smieja M; Kim PT; Lee CH Am J Kidney Dis; 2010 Oct; 56(4):713-9. PubMed ID: 20630640 [TBL] [Abstract][Full Text] [Related]
8. A comparison of responsiveness to hepatitis B vaccination in patients on hemodialysis and peritoneal dialysis. Liu YL; Kao MT; Huang CC Vaccine; 2005 Jun; 23(30):3957-60. PubMed ID: 15917117 [TBL] [Abstract][Full Text] [Related]
9. Extra-high-dose hepatitis B vaccination does not confer longer serological protection in peritoneal dialysis patients: a randomized controlled trial. Chow KM; Lo SH; Szeto CC; Yuen SK; Wong KS; Kwan BC; Leung CB; Li PK Nephrol Dial Transplant; 2010 Jul; 25(7):2303-9. PubMed ID: 20185409 [TBL] [Abstract][Full Text] [Related]
10. Efficacy of intradermal hepatitis B vaccination compared to intramuscular vaccination in hemodialysis patients. Chanchairujira T; Chantaphakul N; Thanwandee T; Ong-Ajyooth L J Med Assoc Thai; 2006 Aug; 89 Suppl 2():S33-40. PubMed ID: 17044452 [TBL] [Abstract][Full Text] [Related]
11. A randomized comparison of intradermal and intramuscular vaccination against hepatitis B virus in incident chronic hemodialysis patients. Charest AF; McDougall J; Goldstein MB Am J Kidney Dis; 2000 Nov; 36(5):976-82. PubMed ID: 11054354 [TBL] [Abstract][Full Text] [Related]
12. [Long-term evaluation of immune response to hepatitis B vaccine in 136 patients undergoing hemodialysis]. Pin M; Compte MT; Angelet P; Gállego C; Gutiérrez C; Martinez Vea A Nefrologia; 2009; 29(5):415-20. PubMed ID: 19820753 [TBL] [Abstract][Full Text] [Related]
13. Effect of high-flux hemodialysis on delayed hepatitis B virus vaccination response in hemodialysis patients. He Q; Wu F; Zhang P; Chen J Postgrad Med; 2011 May; 123(3):150-2. PubMed ID: 21566425 [TBL] [Abstract][Full Text] [Related]
14. Hepatitis B vaccination in predialysis chronic renal failure patients a comparison of two vaccination schedules. McNulty CA; Bowen JK; Williams AJ Vaccine; 2005 Jul; 23(32):4142-7. PubMed ID: 15913854 [TBL] [Abstract][Full Text] [Related]
15. Low-dose intradermal and subcutaneous versus intramuscular hepatitis B vaccination in primary non-responding hemodialysis patients. Sorkhi H; Dooki MR; Ebrahimnejad MS J Med Assoc Thai; 2006 Oct; 89(10):1648-53. PubMed ID: 17128839 [TBL] [Abstract][Full Text] [Related]
16. [Vaccination against hepatitis B in patients with chronic renal failure--twenty years follow-up]. Roznovský L; Tvrdík J; Kabieszová L; Petrousová L; Orságová I; Hozáková L; Lochman I; Kloudová A; Valkovský I; Letocha P; Schwarzová S; Hladík M; Zjevíková A Vnitr Lek; 2011 Oct; 57(10):808-14. PubMed ID: 22097688 [TBL] [Abstract][Full Text] [Related]
17. [Immunogenicity of vaccines against viral hepatitis A and B in the population above 40 years of age -- impact of risk factors]. Chlíbek R; Smetana J; Sindelár R; Cecetková B; Prymula R; Kohl I Epidemiol Mikrobiol Imunol; 2007 Aug; 56(3):119-28. PubMed ID: 17900060 [TBL] [Abstract][Full Text] [Related]
18. [Editorial of the "vaccination issue" of KMIL--what have demonstrated Prevenar and Fendrix vaccines]. Beran J Klin Mikrobiol Infekc Lek; 2006 Jun; 12(3):87-90. PubMed ID: 17051468 [TBL] [Abstract][Full Text] [Related]
19. A prospective study of hepatitis B vaccination - a comparison of responders versus nonresponders. Brown CM; Donlon S; O'Kelly P; Casey AM; Collier C; Conlon PJ; Walshe JJ Ren Fail; 2011; 33(3):276-9. PubMed ID: 21401350 [TBL] [Abstract][Full Text] [Related]
20. Hepatitis B virus serologic markers and anti-hepatitis B vaccination in patients with diabetes. Halota W; Muszyńska M; Pawłowska M Med Sci Monit; 2002 Jul; 8(7):CR516-9. PubMed ID: 12118201 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]